By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MESHAMESHAMESHA
  • Home
  • Who We Are
    • About
    • Management
    • Strategic Plan, 2023-2027
  • Sayansi Magazine
  • Media
    • Audio
    • Videos
    • Photos
  • Membership
    • Accredited Members
    • How to Join MESHA
  • IFAJ 2025 Congress
Search
Categories
  • Climate Change
  • Health
  • Biodiversity
  • Agriculture
  • Environment
© 2024 MESHA. All Rights Reserved.
Reading: Pre-Exposure Prophylaxis uptake is gaining momentum
Share
Sign In
Notification Show More
Font ResizerAa
MESHAMESHA
Font ResizerAa
Search
  • Home
  • Who We Are
    • About
    • Management
    • Strategic Plan, 2023-2027
  • Sayansi Magazine
  • Media
    • Audio
    • Videos
    • Photos
  • Membership
    • Accredited Members
    • How to Join MESHA
  • IFAJ 2025 Congress
Have an existing account? Sign In
Follow US
© 2024 Mesha. All Rights Reserved.
MESHA > Blog > Health > Pre-Exposure Prophylaxis uptake is gaining momentum
Health

Pre-Exposure Prophylaxis uptake is gaining momentum

Mesha
Mesha Published 4 September 2021
Share
3 Min Read
SHARE

A HIV prevention expert has urged Kenyans to continue using Pre-Exposure Prophylaxis (PrEP) as it has proven effective in reducing risk of infection transmission.
Prof Kenneth Ngure, in his address at the 39th edition of Science Media Cafe by the Media for Environment, Science, Health and Agriculture (MESHA), says the
uptake of PrEP was encouraging, especially among key populations.

“One of the main challenges to the uptake of PrEP as a prevention method has been the delivery which requires one to visit a health centre. Innovation on delivery models has seen an increase of one hundred and ten uptakes in the number of people getting on PrEP globally,” he said.

Further, he noted that in addition to the oral PrEP model, WHO has recommended using Dapivirine Vaginal Ring as an HIV prevention method.

According to Prof Ngure, the global target was to have three million people on PrEP before 2020. As at 2021, it is estimated 1.3 million people are on this prevention method.

Oral PrEP is taken in a single tablet every day. The pill prevents the virus from copying itself in the body and contracting of HIV when exposed. The Dapivirine Vagina Ring stays in one’s body for three to six months, it releases chemicals that prevent HIV infection, explained Prof Ngure.

In the just-concluded IAS conference 2021, Microbicide Trial Network (MTN) presented a research study on the adherence of dapivirine vaginal ring and oral PrEP in adolescent girls and young women in Africa. According to Prof Ngure, the research was conducted in Uganda, Zimbabwe and South Africa.

“The efficacy adherence for those over 25 was 61 per cent, those of 25 was 10 per cent, while those between 18-20, there was no efficacy,” said Prof Ngure.

Research reported by AVERT, a UK charity that uses digital communications to build health literacy on HIV and sexual health, on global information and education in HIV and AIDS has shown that PrEP has reduced the risk of HIV infection from unprotected sex by over 90 per cent and more than 70 per cent in people who inject drugs. These statistics include individuals with lower adherence levels.

You Might Also Like

Progress made in keeping HIV at bay

How efforts to counter resistance to Covid jabs have worked

Tales of HIV cure highlight global Aids conference

Media urged to bridge information gap to tackle new HIV infections among youth

15 years and counting: Researcher’s relentless charge against HIV

TAGGED:Pre-exposure prophylaxis

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Whatsapp Whatsapp LinkedIn Email Copy Link Print
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Previous Article Pre-exposure prophylaxis usage gains traction, surpasses PEPFAR target
Next Article Back to drawing board for HIV vaccine search
MESHA gets boost to implement project on Africa-led climate stories
Climate
Presentations from MESHA’s Science Café: Framing Reproductive Health Stories Through Solutions Journalism and Lived Reporting Experiences
Solutions Journalism
Stakeholders out to tackle climate induced malaria surge at Kenya’s coast
Health
Build audience trust through solutions journalism, journalists told
Solutions Journalism

Contact Info

Location
Oasis Apartments, Jogoo Road, 3rd Floor
Phone
+254 721 578517
+254 732 229 230
info@meshascience.org

Facebook

//

We are the number one science, health and agriculture journalists network in Africa accessed by over 20 million users.

Quick Link

  • About
  • Sayansi Magazine
  • Accredited Members
  • Mesha Audio
  • My Bookmarks

Top Categories

  • Climate Change
  • Health
  • Biodiversity
  • Agriculture
  • Environment

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

MESHAMESHA
Follow US
© 2024 MESHA. All Rights Reserved.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?